GAMCO Investors’s Neuronetics STIM Stock Holding History

GAMCO Investors’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$103K	Hold	79,200	–	–	﹤0.01%	923
2026 Q1	$115K	Hold	79,200	–	–	﹤0.01%	989
2025 Q4	$109K	Hold	79,200	–	–	﹤0.01%	1021
2025 Q3	$216K	Buy	79,200 +2,000	+3%	+$7.11K	﹤0.01%	975
2025 Q2	$269K	Hold	77,200	–	–	﹤0.01%	955
2025 Q1	$284K	Sell	77,200 -700	-0.9%	-$2.56K	﹤0.01%	768
2024 Q4	$125K	Sell	77,900 -2,100	-3%	-$2.18K	﹤0.01%	853
2024 Q3	$60.8K	Hold	80,000	–	–	﹤0.01%	860
2024 Q2	$144K	Buy	80,000 +41,500	+108%	+$120K	﹤0.01%	844
2024 Q1	$183K	Hold	38,500	–	–	﹤0.01%	821
2023 Q4	$112K	Sell	38,500 -6,000	-13%	-$9.46K	﹤0.01%	829
2023 Q3	$60.1K	Sell	44,500 -29,000	-39%	-$50.8K	﹤0.01%	835
2023 Q2	$158K	Sell	73,500 -4,000	-5%	-$9.7K	﹤0.01%	820
2023 Q1	$226K	Buy	77,500 +10,000	+15%	+$50.4K	﹤0.01%	818
2022 Q4	$464K	Buy	67,500 +8,000	+13%	+$37.8K	0.01%	703
2022 Q3	$189K	Sell	59,500 -5,500	-8%	-$20K	﹤0.01%	830
2022 Q2	$209K	Sell	65,000 -500	-0.8%	-$1.45K	﹤0.01%	836
2022 Q1	$198K	Sell	65,500 -1,000	-2%	-$3.38K	﹤0.01%	874
2021 Q4	$297K	Buy	66,500 +15,500	+30%	+$75.9K	﹤0.01%	821
2021 Q3	$335K	Buy	51,000 +18,000	+55%	+$173K	﹤0.01%	802
2021 Q2	$529K	Buy	33,000 +16,000	+94%	+$221K	﹤0.01%	751
2021 Q1	$210K	Buy	+17,000	New	+$261K	﹤0.01%	869

Other funds holding STIM

MAM

Madryn Asset Management New York $36.9M AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return

FCM

FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return

Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

MCM

Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GAMCO Investors's STIM Position: Q2 2026 in Review

GAMCO Investors held its Neuronetics (STIM) position steady in Q2 2026 at 79,200 shares worth $103K. The position accounts for ﹤0.01% of the portfolio, ranked #923.

GAMCO Investors first reported a position in STIM in Q1 2021 and has held it in 22 quarters since. The position peaked at $529K in Q2 2021. 86 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

GAMCO Investors held 79,200 shares of Neuronetics worth $103K as of Q2 2026.
GAMCO Investors left its Neuronetics share count unchanged in Q2 2026.
Neuronetics made up ﹤0.01% of GAMCO Investors's portfolio in Q2 2026, its #923 holding.
GAMCO Investors first reported a position in Neuronetics in Q1 2021 and has held it in 22 quarters since.
GAMCO Investors's Neuronetics position peaked at $529K in Q2 2021.
86 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on GAMCO Investors's 13F filing for Q2 2026, filed 12 Aug 2026.